OKLAHOMA CITY – Oklahoma state Senator Kim David, R-Porter, on November 16 released data through the third quarter from the state’s real time, stop-sale pseudoephedrine (PSE) monitoring system, known as the National Precursor Log Exchange (NPLEx).
NPLEx has come to be considered a powerful and proven tool that allows retailers to block sales of cold and allergy medicine containing PSE, such as Claritin-D and Advil Cold and Sinus, when consumers have reached their legally allowed monthly or yearly limit, helping prevent sales to criminals who try to use these safe and effective medicines to make methamphetamine. This tool also provides law enforcement with the information to detect suspicious purchase patterns and identify, prosecute and convict suspected meth makers.
Oklahoma is among the 33 states across the country that have adopted NPLEx as a way to ensure that law-abiding citizens have access to these medicines, while also blocking potentially unlawful PSE purchase attempts in real-time at the point of sale.
Through the first three quarters of 2016, the NPLEx system in Oklahoma helped block the sale of 30,222 boxes of PSE, keeping 76,793 grams of PSE from potentially being used illegally.
“Once again, the most recent data from NPLEx demonstrates how important of a tool that it is in the fight against meth production,” said Sen. David.
“By giving retailers access to real-time information on the amount a potential customer has purchased, it allows them the ability to use the system to reject suspicious purchases.
Furthermore, it helps law enforcement and prosecutors to view purchase patterns as they are identifying and building cases against meth makers. Altogether, along with Oklahoma’s drug offender block list, these tools have played an important role reducing meth lab seizures across the state,” she concluded